Back
MoonLake Immunotherapeutics Vs. Innodata Industry Stock Comparison
Buy
55
MLTX
MoonLake Immunotherapeutics
Last Price:
$49.06
Seasonality Move:
19.98%
Buy
60
INOD
Innodata
Last Price:
$49.72
Seasonality Move:
11.17%
Buy
55
MoonLake Immunotherapeutics (MLTX)
is a Buy
Is MoonLake Immunotherapeutics a Buy, Sell or Hold?
-
The current MoonLake Immunotherapeutics [MLTX] share price is $49.00. The Score for MLTX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
MLTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MLTX Stock Price Chart
What is MoonLake Immunotherapeutics's stock price today?
-
The MoonLake Immunotherapeutics share price today is $49.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLTX is experiencing slight buying pressure.
MLTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 10.78 | Buy |
Relative Strength Index (14 RSI): | 63.01 | Buy |
Chaikin Money Flow: | 152397 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.35 - 48.25) | Buy |
Bollinger Bands (100): | (37.31 - 45.07) | Buy |
INOD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 11.39 | Buy |
Relative Strength Index (14 RSI): | 54.81 | Buy |
Chaikin Money Flow: | -1218826 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.16 - 51.14) | Buy |
Bollinger Bands (100): | (35.62 - 50.5) | Buy |
MLTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.97 | Buy |
20-day SMA: | 46.25 | Buy |
50-day SMA: | 43.24 | Buy |
200-day SMA: | 45.52 | Buy |
8-day EMA: | 30.72 | Buy |
20-day EMA: | 15.94 | Buy |
50-day EMA: | 7.14 | Buy |
200-day EMA: | 1.89 | Buy |
INOD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.23 | Sell |
20-day SMA: | 47.99 | Buy |
50-day SMA: | 43 | Buy |
200-day SMA: | 37.6 | Buy |
8-day EMA: | 32.48 | Buy |
20-day EMA: | 16.93 | Buy |
50-day EMA: | 7.59 | Buy |
200-day EMA: | 2.01 | Buy |
MoonLake Immunotherapeutics Earnings Growth & MLTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.11 per share, a decrease this year of $1.20 per share, and a decrease next year of $0.62 per share.
Innodata Earnings Growth & INOD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.06 per share, and an increase next year of $0.40 per share.
MoonLake Immunotherapeutics Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Innodata Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |